Chromosome breakpoint at 17q11.2 and insertion of DNA from three different chromosomes in a glioblastoma with exceptional glial fibrillary acidic protein expression

Cancer Genetics and Cytogenetics

Volumn 87, Issue 1, 1996, Pages 41-47

  McKeever, Paul E ^a,c   Dennis, Thomas R ^a   Burgess, Ann C ^a   Meltzer, Paul S ^b   Marchuk, Douglas A ^a   Trent, Jeffrey M ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Box 0602 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 10; CHROMOSOME 13; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 20P; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME BREAKAGE; CHROMOSOME LOSS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE INSERTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION;

EID: 0029924015     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00237-5     Document Type: Article

References (38)

1. Bigner SH, Mark J, Bullard DE, Mahaley MS Jr, Bigner DD (1986): Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22:121-135.
2. Bigner SH, Mark J, Burger PC, Mahaley SM Jr, Bullard DE, Muhlbaier LH, Bigner DD (1988): Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 48:405-411.
3. Ransom DT, Ritland SR, Moertel CA, Dahl RJ, O'Fallon JR, Scheithauer BW, Kimmel DW, Kelly PJ, Olopade OI, Diaz MO, Jenkins RB (1992): Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chrom Cancer 5:357-374.
4. Jenkins RB, Kimmel DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989): A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
5. Mark J, Ponten J, Westermark B (1974): Origin of the marker chromosomes in an established hypotriploid glioma cell line studied with G-band technique. Acta Neuropathol (Berl) 29: 223-228.
6. Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J (1987): Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29:201-221.
7. Shapiro JR, Yung W-K A, Shapiro WR (1981): Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res 41:2349-2359.
8. Shitara N, McKeever PE, Whang-Peng J, Knutsen T, Smith BH, Kornblith PL (1983): Flow cytometric and cytogenetic analysis of human cultured cell lines derived from high- and low-grade astrocytomas. Acta Neuropathol 60:40-48.
9. Perentes E, Rubinstein LJ (1987): Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update. Arch Pathol Lab Med 111:796-812.
10. Burger PC, Scheithauer BW, Vogel FS (1991): Surgical Pathology of the Nervous System and Its Coverings, 3rd Ed. Churchill Livingstone, New York, pp. 1-536.
11. McKeever PE, Blaivas M (1994): Surgical pathology of the brain, spinal cord and meninges, In: Diagnostic Surgical Pathology, 2nd Ed., Vol. 1. SS Sternberg, DA Antonioli, D Carter, SE Mills, HA Oberman, eds. Raven Press, New York, pp. 409-492.
12. Bigner DD, Bigner SH, Ponten J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Wikstrand CJ (1981): Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201-229.
13. Jacobsen PH, Jenkyn DJ, Papadimitriou JM (1987): Four permanent cell lines established from human malignant gliomas: Three exhibiting striated muscle differentiation. J Neuropathol Exp Neurol 46:431-450.
14. Westphal M, Haensel M, Mueller D, Laas R, Kunzmann R, Rohde E, Koenig A, Hoelzel F, Herrmann H-D (1988): Biological and karyotypic characterization of a new cell line derived from human gliosarcoma. Cancer Res 48:731-740.
15. Fischer H, Schwechheimer K, Heider M, Bernhardt S, Zang KD (1985): Establishment and characterization of a human glioblastoma cell line with a stable karyotype and nullisomy 13. Cancer Genet Cytogenet 17:257-268.
16. Zulch KJ (1979): Histological typing of tumours of the central nervous system. International Histological Classification of Tumours, no. 21. World Health Organization, Geneva, pp. 1-66.
17. Kleihues P, Burger PC, Scheithauer BW (1993): The new WHO classification of brain tumours. Brain Pathol 3:255-268.
18. Trent JM, Thompson FH (1987): Methods for chromosome banding of human and experimental tumors in vitro. In: Methods in Enzymology, vol. 151, M. Gottesman, ed. Academic Press, New York, pp. 267-279.
19. Goodman BK, Xu W-T, Nottoli V, Rundall-Jackson T, Stock AD (1985): A simplified technique for bone marrow preparations with modified hypotonic treatment. Karyogram 11:95-96.
20. McKeever PE, Smith BH, Taren JA, Wahl RL, Kornblith PL, Chronwall BM (1987): Products of cells cultured from gliomas: VI. Immunofluorescent, morphometric, and ultrastructural characterization of two different cell types growing from explants of human gliomas. Am J Pathol 127:358-372.
21. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J (1988): Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 85:9138-9142.
22. Marchuk DA, Tavakkol R, Wallace MR, Brownstein BH, Taillon-Miller P, Fong CT, Legius E, Andersen LB, Glover TW, Collins FS (1992): A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene. Genomics 13:672-680.
23. Meltzer PS, Guan X-Y, Burgess A, Trent JM (1992): Rapid generation of region specific probes by chromosome microdissection and their application. Nature Genet 1:24-28.
24. Guan X-Y, Meltzer PS, Dalton WS, Trent JM (1994): Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet 8:155-161.
25. ISCN (1985): An International System for Human Cytogenetic Nomenclature. Harnden DG, Klinger HP (eds.); published in collaboration with Cytogenet Cell Genet (Karger, Basel, 1985); also in Birth Defects: Original Article Series, Vol. 21, No. 1 (March of Dimes Birth Defects Foundation, New York, 1985).
26. Decker HJH, Cannizzaro LA, Mendez MJ, Leong SPL, Bixenman H, Berger C, Sandberg AA (1990): Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study. Hum Genet 85:337-342.
27. Paakko P, Nuorva K, Kamel D, Soini Y (1992): Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas. Am J Respir Cell Mol Biol 7:325-334.
28. Bongcam-Rudloff E, Nister M, Betsholz C, Wang JL, Stenman G, Huebner K, Croce CM, Westermark B (1991): Human glial fibrillary acidic protein: Complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes. Cancer Res 51:1553-1560.
29. Bernstein JJ, Anagnostopoulos AV, Hattwick EA, Laws ER Jr (1993): Human-specific c-neu proto-oncogene protein overexpression in human malignant astrocytomas before and after xenografting. J Neurosurg 78:240-251.
30. Walker AE (1941): Astrocytosis Arachnoideae cerebelli. A rare manifestation of von Recklinghausen's neurofibromatosis. Arch Neurol Psychol 45:520-532.
31. Ilgren EB, Stiller CA (1987): Cerebellar astrocytomas part II. Pathologic features indicative of malignancy. Clin Neuropathol 6:201-214.
32. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R (1992): Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275-281.
33. Bigner SH, Mark J, Bigner DD (1987): Chromosomal progression of malignant human gliomas from biopsy to establishment as permanent lines in vitro. Cancer Genet Cytogenet 24:163-176.
34. Bigner SH, Schold SC, Friedman HS, Mark J, Bigner DD (1989): Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice. Cancer Genet Cytogenet 40:111-120.
35. Rey JA, Bello MJ, Ramos C, Benitez J, Muelas JM (1983): Serial cytogenetic study of human glioma cell line. Cancer Genet Cytogenet 8:287-295.
36. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK (1988): Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551.
37. El-Azouzi M, Chung RY, Farmer GE, Martuza RL, Black PM, Rouleau GA, Hettlich C, Hedley-Whyte ET, Zervas NT, Panagopoulos K, Nakamura Y, Gusella JF, Seizinger BR (1989): Loss of distinct regions of the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas. Proc Natl Acad Sci USA 86:7186-7190.
38. Ray ME, Guan X-Y, Slovak ML, Trent JM, Meltzer PS (1994): Rapid detection, cloning and molecular cytogenetic characterisation of sequences from an MRP-encoding amplicon by chromosome microdissection. Br J Cancer 70:85-90.